A Digital Treatment for Adolescents With Eating Disorders

NCT06306586 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-22

No results posted yet for this study

Summary

The goal of this feasibility study is to evaluate the feasibility and preliminary clinical outcomes of a personalized digital treatment for adolescents with eating disorders. The main objectives are to:

i) Evaluate whether a personalized digital treatment for adolescents with eating disorders are feasible in a child and adolescent psychiatric outpatient clinic.

ii) Evaluate who benefits from a personalized digital treatment for adolescents with eating disorders (what works for whom?) iii) Evaluate the cost-benefit of a personalized digital treatment for adolescents with eating disorders.

Participants will be enrolled in a 10-week digital treatment including weekly therapist contact. They will be asked to complete self-report questionnaires at pre-, during, post- and 3- and 6-months follow-up.

Conditions

Interventions

BEHAVIORAL

Digital Treatment for Adolescents With Eating Disorders

The main aim of the digital treatment is to reduce symptoms of eating disorders and increase life-coping skills. The digital treatment aims to help adolescents with eating disorders to: * Gain knowledge about the symptoms of eating disorders and the consequences it has on everyday life. * Be motivated to carry out the treatment. * Gain knowledge of and skills in regulating food and activity in a more balanced way. * Gain knowledge of and skills in managing emotions. * Get tools to develop a better self-esteem. * Gain awareness of the function of the eating disorder. * Gain skills in coping with social challenges. * Get a more realistic image of their bodies and handle information from social media.

Sponsors & Collaborators

  • Helse Fonna

    collaborator OTHER
  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Tine Nordgreen, PhD · Division of Psychiatry, Haukeland University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2027-01-01
Completion
2027-01-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06306586 on ClinicalTrials.gov